Bristow Secures First Delivery Slot for Electra's EL9 Ultra Short Aircraft with Multi-Million-Dollar PDP Agreement

Ensysce Biosciences has received a patent allowance from the Brazilian Patent Office for its TAAP and MPAR technologies, expanding its opioid patent portfolio. The patent covers additional opioid families and includes composition of matter and method of use claims, further strengthening Ensysce's intellectual property estate. This expansion aims to reduce abuse and overdose while maintaining pain relief, advancing safer pain treatment options.